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Changing Profile of the Cardiac Donor
Adverse Prognosis of an Unsuccessful Mitral
Valve Repair Immediately Followed by Valve
Replacement: Value of Echocardiography
Irene M. Hellemans, Els G. Pieper, Anita C.J. Ravelli, Johannes P.M. Hamer,
Wybren Jaarsma, Emile C. Cheriex, Henry A. van Swieten, Cathinka H. Peels, Jan
G.P. Tyssen, eees A. Visser, ESMIR (Echocardiographic Selection of patients for
Mitral valve Repair). Interuniversity Cardiology Institute (IClNI, Utrecht, The Netherlands
To determine the risk of an unsuccessful mitral valve repair followed by re-
placement we prospectively studied 180 patients (pts) who underwent mi-
tral valve surgery because of severe regurgitation using univariate analysis
of preoperative clinical, echocardiographic and surgical characteristics.
Clinical and echocardiographic risk factors for unsuccessful repair were:
female gender (relative risk (RR) 2.56*). concomitant mitral stenosis (RR
4.63*). restricted leaflet mobility (RR 2.48*), normal left ventricular enddias-
tolic diameter (RR 3.42*) and prediction of a replacement by echo (RR 4.74*).
Surgical risk factors were: restricted leaflet mobility (RR 4.0*), concomitant
mitral stenosis (RR 4.83*) and aneurysm of the left ventricle (RR 3.17*).
In 12 pts the result of the repair procedure was deemed unsatisfactory
after visual inspection and in 9 pts the replacement procedure was carried
out on the basis of intraoperative echo assessment of residual regurgitation.
One year mortality of these 21 patients was 24% and the RR of death was
2.15* compared to primary replacement pts. (*p < 0.005)
Conclusions:
1. Risk factors for an unsuccessful repair can readily be identified by pre-
operative echocardiography and determination of gender.
2. Unsuccessful mitral valve repair followed by valve replacement during
the same surgical procedure is related to a substantial one-year mortality.
As the demand for organs for cardiac transplantation has increased, donor
criteria have evolved. We reviewed the characteristics of 190 cardiac donors
from 1983 to 1993 to identify trends in donor profile and to determine if recip-
ient outcome were affected. Donors were divided into early(1983-1 987; n =
86) and late (1988-1993; n = 104) groups according to operative era, While
mean donor age has not changed significantly (24 ± 0.9 to 26 ± 1.3 years),
the proportion of donors older than 40 years has increased from 1% (1/86)
to 15% (16/104) (p < 0.001). Trauma was the cause of death in 93% (80/86)
of the early group and 65% of the late group (68/104) (p < 0.001); in the total
series, donors older than 40 years were less likely to have died from trauma
131%; 5/16) than younger donors (83%; 143/173) (p = 0.001). The propor-
tion of out-of-state donors has fallen from 71 % (61/86) to 27% (28/104) (p <
0.001), while the proportion of ethnic minorities increased from 10% (9/86) to
25% (26/1041 (p < 0.001). There have been no significant changes in gender
profile; males constituted 78% (67/86) of the early group and 72% (75/104)
of the late group. Five year survival after transplant was not predicted by
donor age, mode of donor death, recipient age, or recipient UNOS status.
In summary, donors in the current era are more likely (1) to be older, (2) to
be within the state, (3) to come from an ethnic minority, and (4) to have died
from causes other than trauma when compared to donors from the earlier
era.
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Biopsy Negative Left Ventricular Dysfunction
After Cardiac Transplantation: Outcome and Role
of Enhanced Immunosuppression
Months After CT
LVEF
Blocompatible Mechanical Left Ventricular
Support: Potential Alternative to Transplantation
Valluvan Jeevanandam, Barbara Todd, Satoshi Furukawa, James McClurken,
Abhi Pathak, Howard Eisen, Carol Fisher, V. Paul Addonizio. Temple UniversitY-
Philadelphia, PA
Pre-implant POD 7 POD 28
Cardiac index (I/min/m2 ) 1.8 ± 07 3.2 ± 0.4 31 ± 05
Systolic BP ImmHg) 759 ± 6.8 125.8 ± 97 130.4 ± 8.1
Hemoglobin Img/dl) 7.4 ± 18 8.2 ± 1.6 96 ± 2.0
Plasma free hemoglobin (mg/dl) 15.4±1.7 6.4 ± 2.3 6.8 ± 19
Prothrombin time (sec) 142 ± 1.1 13.4 ± 0.7 13.3 ± 07
Partial thromboplastin time (secl 56.7 ± 15.9 31.8 ± 4.8 37.6 ± 11.9
Platelet count (x 103leu mml 250 ± 81 269 ± 63 325 ± 37
LV function improved spontaneously in 1 pI. The remaining 8 pts received
ENIM for presumed rejection. Therapy included solumedrol in 7/8 pts. OKT3
in 4/8 pts, and actinomycin 2/8 pts. LVEF improved in 5/8, but returned to
initial baseline only in 2 pts; 3 pts died within 2 months of presentation,
despite therapy.
In summary: 1. LV dysfunction, unexplained by cellular rejection or an-
giographic evidence of coronary disease, occurred in 10% of pts within 2
years of CT. 2. Despite negative histology, LVEF improved in 62% of these
pts treated with enhanced immunosuppression.
To evaluate the incidence and etiology of LV dysfunction (LVD) occurring with-
out cellular rejection after cardiac transplantation (CT). we retrospectively
reviewed all echocardiograms from 93 consecutive CT recipients at Mas-
sachusetts General Hospital. A decrease in LVEF to <0.45 in the absence of
secondary causes occurred in 15 patients (pts) (13 M, 2 F). RV biopsies (bx)
showed moderate cellular rejection (ISHLT grade 2 to 3A) in 4/15 patients; 3/4
pts improved following therapy with enhanced immunosuppression IENIM).
Diagnostic studies in the 11 pts without cellular rejection included LV bx 15
pts) and immunofluorescence staining for vascular rejection (4 pts); all were
negative. Coronary angiography was performed in 10/11 pts and revealed
mild distal disease in 2 pts. These 2 pts died within four months of angiog-
raphy, and had diffuse coronary artery disease (CAD) at autopsy. Change in
LVEF over time in the 9 pts without CAD were;
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Use of mechanical circulatory support has been limited by its associated
bleeding and thrombotic complications. Blood contact with an artificial sur-
face results in a well-deined pattern of hematologic alterations. The TCI
HeartMate® left ventricular assist device (LVAD) is an implantable circula-
tory support pump currently used as a bridge to transplantation. Its textured
blood contacting surfaces result in a formation of an adherent pseudoneoin-
timal lining which eliminates the direct interaction of blood elements with
the artificial surface. To determine if this biological lining could mitigate the
stereotypical blood-synthetic surface interactions, we studied eight patients
who underwent implantation at our institution over a 10 month period from
5/93 to 3/94. Seven of the 8 patients were bridged to transplantation. Three
patients were transplanted within 10 days and one month data could not
be obtained. Hemodynamic and hemostatic parameters (mean ± sd) were
studied as follows:
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In vitro platelet reactivity to the agonist ADP remained normal pre and post
implantation. Average perioperative blood requirements included PRBC, 3.3
± 1.3 units; platelets, 2.3 ± 4.5 units; fresh frozen plasma, 2 ± 1.9 units. No
blood products were required after postoperative day 2.
We conclude that TCI LVAD support improves hemodynamics and can
bridge patients in pre-implant cardiogenic shock to transplantation. Further-
more, no red cell destruction or hemostatic and thrombotic complications
were observed despite one month of support without anticoagulation ther-
apy. Therefore, as the donor shortage continues, LVADs with biocompatible
surfaces may provide an alternative to cardiac transplantation.
Digitally Compressed Echocardlograms Offer
Superior Image and Diagnostic Quality to Video
Tape: Results of the Digital ERA (Echo Record
Access) Study
Tom H. Karson, Shalabh Chandra, Richard C. Zepp, Nancy A. Obuchowski, Robert
M. Hill, Aaron S. Waitz, J.P. Patten, James D. Thomas. Cleveland Clinic Foundation,
Cleveland, Ohio
Routine use of digital echocardiography has many advantages but re-
quires inordinate amounts of computer memory. Storing compressed im-
ages would reduce memory needs; however, image quality(IO) and diagnos-
tic quality (DO) may suffer. To gather data from a wide variety of echo users,
attendees of the 1994 American Society of Echocardiography Scientific Ses-
sions were asked to participate in a study comparing the 10 and DO of digi-
tal images against images digitized from video tape of the same structures.
